Table 1.
Study | Country | Date | Sample size No. (IG/CG); Sex (%) | Intervention | Control intervention | Method of delivery | Duration of intervention, wk | Study Design | Targeted domain | Sexuality-related outcome measures |
---|---|---|---|---|---|---|---|---|---|---|
Zamani et al,33 2017 | Iran | NR | 30 (15/15); 100% female | Psychosexual therapy (education, relaxation, exercises, self-exploration, homework) | Waitlist CG | Group sessions | 12 | RCT with pre-post assessment | QOL (MSQOL-54) and sexual dysfunctions measured by FSFI | FSFI subscales: Desire P = .0001; Arousal P = .022; Lubrication P = .001; Orgasm P = .001; Satisfaction P = .0001; Pain P =.026; Satisfaction with sexual function (MSQOL-54) P < .001; Sexual functioning (MSQOL-54) P < .001 |
Abbreviations: CBT, cognitive behavioral therapy; CG, control group; FSFI, Female Sexual Function Index; IG, intervention group; MSI, Marital Satisfaction Inventory; MSISQ-19, Multiple Sclerosis Intimacy and Sexuality Questionnaire-19; MSQOL-54, Multiple Sclerosis Quality of Life–54; NR, not reported; PLISSIT, Permission, Limited Information, Specific Suggestions, Intensive Therapy; QOL, quality of life; RCT, randomized controlled trial; SSS, Sexual Satisfaction Survey.